Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Complement decay accelerating factor (DAF)/CD55 in cancer.

Ian Spendlove1, Judith M Ramage, Richard Bradley

  • 1CR UK Academic Department of Clinical Oncology, Institute of Infections Immunity and Inflammation, The University of Nottingham, NG5 1PB, Nottingham, UK. Ian.Spendlove@Nottingham.ac.uk

Cancer Immunology, Immunotherapy : CII
|February 18, 2006
PubMed
Summary

The complement system protects against pathogens but can cause disease. Complement regulatory proteins (CRPs), like CD55, control this system and are altered in cancer, potentially affecting immune cell function.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Single-Cell Transcriptomic Analysis Reveals γδ T-Cell Infiltration and Presence of Immune Regulatory Molecules in Biliary Tract Cancer Microenvironment.

American journal of clinical oncology·2026
Same author

Effects of Increasing the Concentration of Dialysate Magnesium on Cardiovascular Health: A Narrative Review.

Canadian journal of kidney health and disease·2026
Same author

Inconsistencies in care: a UK and Ireland survey exploring acute vestibular service provision in adult major trauma centres.

Frontiers in neurology·2026
Same author

Establishing a National Quality Improvement Program for Nephrology Fellows: The Canadian Society of Nephrology Experience.

Canadian journal of kidney health and disease·2025
Same author

Outcomes of Adopting a Higher Versus Lower Concentration of Hemodialysate Magnesium as a Center-Wide Policy (Dial-Mag): A Clinical Research Protocol of a Pragmatic, Registry-Based, Cluster Randomized Trial.

Canadian journal of kidney health and disease·2025
Same author

Epigenetic Regulation of Immune Responses in Endocrine-Related Cancers and Its Role in Immunotherapy.

Cancers·2025

Area of Science:

  • Immunology
  • Cell Biology

Background:

  • The complement system is crucial for innate immunity, pathogen defense, and clearing apoptotic cells.
  • It plays a role in diseases like autoimmunity and graft rejection.
  • Complement regulatory proteins (CRPs) control complement activation and protect host cells.

Purpose of the Study:

  • To review CRP expression in cancer, focusing on CD55.
  • To highlight CRPs' roles in leukocyte function.
  • To present data on soluble CD55 inhibiting T-cell function and discuss implications.

Main Methods:

  • Review of scientific literature on complement regulatory proteins (CRPs) and cancer.
  • Analysis of CRP expression patterns in various pathologies, particularly cancer.
  • Experimental data investigating the mechanism of soluble CD55 on T-cell function.

Related Experiment Videos

Main Results:

  • CRPs, including CD55, show altered expression (up/down-regulation, secretion, loss) in cancer.
  • CRPs are involved in leukocyte function.
  • Soluble CD55 was shown to potentially inhibit T-cell function.

Conclusions:

  • Altered CRP expression in cancer impacts immune responses.
  • CD55's role in regulating complement and its potential to inhibit T-cells warrants further investigation in cancer therapy.